Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ERK1/2, p Thr202, p Tyr204, p Thr185, p Tyr187 Antibody (SC58-01), Novus Biologicals™

Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP267555
Description
ERK1/2 Monoclonal specifically detects ERK1/2 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunoprecipitation.Specifications
ERK1/2 (p Thr202, p Tyr204, p Thr185, p Tyr187) | |
Monoclonal | |
1 mg/mL | |
Western Blot 1:500-1:2000, Immunohistochemistry 1:400, Immunoprecipitation, Immunohistochemistry-Paraffin 1:1000 | |
EC 2.7.11, ERK-1, ERK1p44-MAPK, ERT2, Extracellular signal-regulated kinase 1, extracellular signal-related kinase 1, HS44KDAP, HUMKER1A, Insulin-stimulated MAP2 kinase, MAP kinase 1, MAP kinase 3, MAP kinase isoform p44, MAPK 1, MAPK 3, MGC20180, Microtubule-associated protein 2 kinase, Mitogen-activated protein kinase 1, mitogen-activated protein kinase 3, p44erk1, p44-ERK1, p44mapk, PRKM3EC 2.7.11.24 | |
Rabbit | |
Protein A purified | |
Alzheimers Research, Angiogenesis, Apoptosis, Breast Cancer, Cancer, Caspases, Cell Cycle and Replication, Diabetes Research, Hypoxia, MAP Kinase Signaling, mTOR Pathway, Neurodegeneration, Phospho Specific, Protein Kinase, Signal Transduction | |
5595 | |
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
IgG |
Immunoprecipitation, Western Blot | |
SC58-01 | |
Unconjugated | |
TBS (pH7.4), 0.05% BSA, 40% Glycerol with 0.05% Sodium Azide | |
MAPK3 | |
Synthetic peptide within Human aa 166-215/ 379. (SwissProt: P27361 Human; SwissProt: P28482 Human; SwissProt: P63085 Mouse; SwissProt: Q63844 Mouse; SwissProt: P21708 Rat; SwissProt: P63086 Rat) | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction